399 related articles for article (PubMed ID: 19273066)
1. Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance.
Tziomalos K; Hare JM
Front Biosci (Landmark Ed); 2009 Jan; 14(1):237-62. PubMed ID: 19273066
[TBL] [Abstract][Full Text] [Related]
2. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.
Saraiva RM; Minhas KM; Zheng M; Pitz E; Treuer A; Gonzalez D; Schuleri KH; Vandegaer KM; Barouch LA; Hare JM
Nitric Oxide; 2007 May; 16(3):331-8. PubMed ID: 17307368
[TBL] [Abstract][Full Text] [Related]
3. Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension.
Oliveira-Paula GH; Pinheiro LC; Guimaraes DA; Tella SO; Blanco AL; Angelis CD; Schechter AN; Tanus-Santos JE
Redox Biol; 2016 Aug; 8():398-406. PubMed ID: 27078869
[TBL] [Abstract][Full Text] [Related]
4. Nitrite-mediated reduction of macrophage NADPH oxidase activity is dependent on xanthine oxidoreductase-derived nitric oxide but independent of S-nitrosation.
Zollbrecht C; Persson AE; Lundberg JO; Weitzberg E; Carlström M
Redox Biol; 2016 Dec; 10():119-127. PubMed ID: 27744114
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how.
Cantu-Medellin N; Kelley EE
Nitric Oxide; 2013 Nov; 34():19-26. PubMed ID: 23454592
[TBL] [Abstract][Full Text] [Related]
6. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.
Khan SA; Lee K; Minhas KM; Gonzalez DR; Raju SV; Tejani AD; Li D; Berkowitz DE; Hare JM
Proc Natl Acad Sci U S A; 2004 Nov; 101(45):15944-8. PubMed ID: 15486091
[TBL] [Abstract][Full Text] [Related]
7. Interaction between neuronal nitric oxide synthase signaling and temperature influences sarcoplasmic reticulum calcium leak: role of nitroso-redox balance.
Dulce RA; Mayo V; Rangel EB; Balkan W; Hare JM
Circ Res; 2015 Jan; 116(1):46-55. PubMed ID: 25326127
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.
Pinheiro LC; Oliveira-Paula GH; Portella RL; Guimarães DA; de Angelis CD; Tanus-Santos JE
Redox Biol; 2016 Oct; 9():134-143. PubMed ID: 27521759
[TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation.
Cantu-Medellin N; Kelley EE
Redox Biol; 2013 Jun; 1(1):353-8. PubMed ID: 24024171
[TBL] [Abstract][Full Text] [Related]
10. New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity.
Furuhashi M
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E827-E834. PubMed ID: 32893671
[TBL] [Abstract][Full Text] [Related]
11. The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Battelli MG; Bortolotti M; Polito L; Bolognesi A
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2557-2565. PubMed ID: 29733945
[TBL] [Abstract][Full Text] [Related]
12. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
[TBL] [Abstract][Full Text] [Related]
13. Aberrant S-nitrosylation mediates calcium-triggered ventricular arrhythmia in the intact heart.
Cutler MJ; Plummer BN; Wan X; Sun QA; Hess D; Liu H; Deschenes I; Rosenbaum DS; Stamler JS; Laurita KR
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):18186-91. PubMed ID: 23071315
[TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidoreductase: One enzyme for multiple physiological tasks.
Bortolotti M; Polito L; Battelli MG; Bolognesi A
Redox Biol; 2021 May; 41():101882. PubMed ID: 33578127
[TBL] [Abstract][Full Text] [Related]
15. The double faced role of xanthine oxidoreductase in cancer.
Chen MM; Meng LH
Acta Pharmacol Sin; 2022 Jul; 43(7):1623-1632. PubMed ID: 34811515
[TBL] [Abstract][Full Text] [Related]
16. Xanthine Oxidoreductase-Derived Reactive Species: Physiological and Pathological Effects.
Battelli MG; Polito L; Bortolotti M; Bolognesi A
Oxid Med Cell Longev; 2016; 2016():3527579. PubMed ID: 26823950
[TBL] [Abstract][Full Text] [Related]
17. Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.
Agarwal A; Banerjee A; Banerjee UC
Crit Rev Biotechnol; 2011 Sep; 31(3):264-80. PubMed ID: 21774633
[TBL] [Abstract][Full Text] [Related]
18. Xanthine oxidoreductase in cancer: more than a differentiation marker.
Battelli MG; Polito L; Bortolotti M; Bolognesi A
Cancer Med; 2016 Mar; 5(3):546-57. PubMed ID: 26687331
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
Polito L; Bortolotti M; Battelli MG; Bolognesi A
Pharmacol Res; 2022 Oct; 184():106407. PubMed ID: 35995347
[TBL] [Abstract][Full Text] [Related]
20. Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance.
Dulce RA; Yiginer O; Gonzalez DR; Goss G; Feng N; Zheng M; Hare JM
J Biol Chem; 2013 Mar; 288(9):6522-33. PubMed ID: 23319593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
